Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Dtxsid60952839
2. 5-({3-(acetylsulfanyl)-1-[(carboxymethyl)imino]-1-hydroxypropan-2-yl}imino)-5-hydroxynorvaline
3. Refchem:1072301
4. Dtxcid601380912
5. S-acetyl-l-glutathione
6. 5-[[3-acetylsulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-2-amino-5-oxopentanoic Acid
7. C12h19n3o7s
8. 5-[[1-(acetylsulfanylmethyl)-2-(carboxymethylamino)-2-oxo-ethyl]amino]-2-amino-5-oxo-pentanoic Acid
9. Glutathione-s-acetate
10. Schembl420277
11. Orb2279192
12. Fvrwsipjnwxceo-uhfffaoysa-n
13. (2s)-4-{[(1r)-2-(acetylsulfanyl)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-2-aminobutanoic Acid
14. Bcp09327
15. Akos025404546
16. Ds-9100
17. Fs165201
18. Ns00047864
19. S-acetyl-?-l-glutamyl-l-cysteinyl-glycine;sag
| Molecular Weight | 349.36 g/mol |
|---|---|
| Molecular Formula | C12H19N3O7S |
| XLogP3 | -4.4 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 201 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 483 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE